Trials / Completed
CompletedNCT01561807
A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus
A Phase 2a, Randomized, Double-Blind,Placebo-Controlled Study to Investigate the Effects of VX-787 Administered to Adult Volunteers Experimentally Inoculated With Live Influenza Virus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Vertex Pharmaceuticals Incorporated · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the antiviral activity and safety of VX-787 given to healthy adult volunteers that have been inoculated with the influenza virus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VX-787 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-10-01
- First posted
- 2012-03-23
- Last updated
- 2016-09-02
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01561807. Inclusion in this directory is not an endorsement.